Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1182]
News [2577]
Articles [164]
Editorials [8]
Conferences [107]
elearning [18]
ESMO 2025: Precision medicine in bladder cancer
Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix...
ESMO 2025: Precision medicine in bladder cancer ( Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos )
22 Oct 2025
ESMO 2025: Latest in mRCC
Dr Javier Puente, Prof Jens Bedke, Prof Laurence Albiges and Prof Viktor...
ESMO 2025: Latest in mRCC ( Dr Javier Puente, Prof Jens Bedke, Prof Laurence Albiges and Prof Viktor Grünwald )
22 Oct 2025
ctDNA test guides post-surgical immunotherapy for muscle-invasive bladder cancer
Dr Joaquim Bellmunt - Dana-Farber Cancer Institute, Boston, USA
ctDNA test guides post-surgical immunotherapy for muscle-invasive bladder cancer ( Dr Joaquim Bellmunt - Dana-Farber Cancer Institute, Boston, USA )
20 Oct 2025
Neoadjuvant TAR-200 plus cetrelimab improves PCR in muscle-invasive bladder...
Prof Andrea Necchi - Vita-Salute San Raffaele University, Milan, Italy
Neoadjuvant TAR-200 plus cetrelimab improves PCR in muscle-invasive bladder cancer ( Prof Andrea Necchi - Vita-Salute San Raffaele University, Milan, Italy )
20 Oct 2025
Visugromab plus nivolumab significantly increases pathologic response in muscle...
Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Visugromab plus nivolumab significantly increases pathologic response in muscle-invasive bladder cancer ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )
20 Oct 2025
ESMO 2025: Prostate highlights
Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...
ESMO 2025: Prostate highlights ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
20 Oct 2025
ESMO 2025: Bladder cancer highlights
Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...
ESMO 2025: Bladder cancer highlights ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
20 Oct 2025
ESMO 2025: Renal highlights
Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...
ESMO 2025: Renal highlights ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
20 Oct 2025
177Lu-PSMA-617 with androgen deprivation therapy plus ARPI improves PFS for...
Dr Scott Tagawa - Weill Cornell Medicine, New York, USA
177Lu-PSMA-617 with androgen deprivation therapy plus ARPI improves PFS for mHSPC ( Dr Scott Tagawa - Weill Cornell Medicine, New York, USA )
20 Oct 2025
ctDNA-guided adjuvant atezolizumab improves OS in MIBC
Prof Thomas Powles - Barts Cancer Institute, London, UK
ctDNA-guided adjuvant atezolizumab improves OS in MIBC ( Prof Thomas Powles - Barts Cancer Institute, London, UK )
20 Oct 2025
177Lu-PSMA-617 in metastatic castration-resistant prostate cancer shows higher...
Dr Kim Nguyen Chi - BC Cancer, British Columbia, Canada
177Lu-PSMA-617 in metastatic castration-resistant prostate cancer shows higher PSA response with lower toxicity ( Dr Kim Nguyen Chi - BC Cancer, British Columbia, Canada )
20 Oct 2025
Best practice in precision medicine for prostate cancer
Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich
Best practice in precision medicine for prostate cancer ( Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich )
20 Oct 2025

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation